| Patent | Date |
|---|
CHIMERIC PROTEINS FOR TARGETING dsRNA
App 20220213158 - LEVITZKI; Alexander ; et al. | 2022-07-07 |
Immunotherapy For The Treatment Of Cancer
App 20220175814 - BROKA; Derrick ; et al. | 2022-06-09 |
Chimeric proteins for targeting dsRNA
Grant 11,230,580 - Levitzki , et al. January 25, 2 | 2022-01-25 |
A Recombinant Protein Comprising A Double Stranded Rna Binding Domain
App 20200407453 - LEVITZKI; Alexander ; et al. | 2020-12-31 |
Castration Resistant Prostate Cancer
App 20200230248 - POMBO-VILLAR; Esteban ; et al. | 2020-07-23 |
CHIMERIC PROTEINS FOR TARGETING dsRNA
App 20190194282 - LEVITZKI; Alexander ; et al. | 2019-06-27 |
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
Grant 10,188,659 - Reuveni , et al. Ja | 2019-01-29 |
CHIMERIC PROTEINS FOR TARGETING dsRNA
App 20180346596 - LEVITZKI; Alexander ; et al. | 2018-12-06 |
Igf-1r Signaling Pathway Inhibitors Useful In The Treatment Of Neurodegenerative Diseases
App 20180064725 - REUVENI; Hadas ; et al. | 2018-03-08 |
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
Grant 9,770,454 - Reuveni , et al. September 26, 2 | 2017-09-26 |
Igf-1r Signaling Pathway Inhibitors Useful In The Treatment Of Neurodegenerative Diseases
App 20160158243 - REUVENI; Hadas ; et al. | 2016-06-09 |
Compounds for treatment of cell proliferative diseases
Grant 9,096,499 - Priebe , et al. August 4, 2 | 2015-08-04 |
2-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the treatment of cancer
Grant 9,073,880 - Reuveni , et al. July 7, 2 | 2015-07-07 |
EGFR-homing double-stranded RNA vector for systemic cancer treatment
Grant 9,006,406 - Levitzki , et al. April 14, 2 | 2015-04-14 |
Compounds For Treatment Of Cell Proliferative Diseases
App 20140329901 - PRIEBE; Waldemar ; et al. | 2014-11-06 |
Quinazoline-based T cell proliferation inhibitors
Grant 8,759,363 - Levitzki , et al. June 24, 2 | 2014-06-24 |
Compounds for treatment of cell proliferative diseases
Grant 8,648,102 - Priebe , et al. February 11, 2 | 2014-02-11 |
Modulators of protein kinase signaling
Grant 8,637,575 - Reuveni , et al. January 28, 2 | 2014-01-28 |
2-(2-phenylethenyl) 1,3-benzodiazepine Compounds Useful For The Treatment Of Cancer
App 20130274251 - Reuveni; Hadas ; et al. | 2013-10-17 |
Polyalkylene glycol derivatives of inhibitors of epidermal growth factor receptor tyrosine kinase
Grant 8,461,166 - Mishani , et al. June 11, 2 | 2013-06-11 |
Quinazoline-based T Cell Proliferation Inhibitors
App 20130109706 - Levitzki; Alexander ; et al. | 2013-05-02 |
Targeted double stranded RNA mediated cell killing
Grant 8,372,818 - Shir , et al. February 12, 2 | 2013-02-12 |
Compounds For Treatment Of Cell Proliferative Diseases
App 20120214850 - Priebe; Waldemar ; et al. | 2012-08-23 |
Novel Protein Kinase Modulators And Therapeutic Uses Thereof
App 20120083528 - Reuveni; Hadas ; et al. | 2012-04-05 |
Compounds for treatment of cell proliferative diseases
Grant 8,119,827 - Priebe , et al. February 21, 2 | 2012-02-21 |
Egfr-homing Double-stranded Rna Vector For Systemic Cancer Treatment
App 20120021006 - Levitzki; Alexander ; et al. | 2012-01-26 |
Protein kinase modulators and therapeutic uses thereof
Grant 8,058,309 - Reuveni , et al. November 15, 2 | 2011-11-15 |
Selective killing of cells by activation of double-stranded RNA dependent protein kinase-PKR
Grant 8,044,032 - Shir , et al. October 25, 2 | 2011-10-25 |
Targeted Double Stranded Rna Mediated Cell Killing
App 20110177102 - SHIR; Alexei ; et al. | 2011-07-21 |
Novel Modulators Of Protein Kinase Signaling
App 20110105618 - Reuveni; Hadas ; et al. | 2011-05-05 |
Targeted double stranded RNA mediated cell killing
Grant 7,927,792 - Shir , et al. April 19, 2 | 2011-04-19 |
Compounds For Treatment Of Cell Proliferative Diseases
App 20110021805 - Priebe; Waldemar ; et al. | 2011-01-27 |
Compounds for treatment of cell proliferative diseases
Grant 7,745,468 - Priebe , et al. June 29, 2 | 2010-06-29 |
Novel Protein Kinase Modulators And Therapeutic Uses Thereof
App 20100056635 - Reuveni; Hadas ; et al. | 2010-03-04 |
Cell permeable conjugates of peptides for inhibition of protein kinases
App 20090156507 - Livnah; Narit ; et al. | 2009-06-18 |
Polyalkylene glycol derivatives of inhibitors of epidermal growth factor receptor tyrosine kinase
App 20080056990 - Mishani; Eyal ; et al. | 2008-03-06 |
Method and compositions for inhibiting cell proliferative disorders
Grant 7,217,737 - Chen , et al. May 15, 2 | 2007-05-15 |
Cell permeable conjugates of peptides for inhibition of protein kinases
App 20070078092 - Livnah; Nurit ; et al. | 2007-04-05 |
Selective killing of cells by activation of double-stranded RNA dependent protein kinase-PKR
App 20070036764 - Shir; Alexei ; et al. | 2007-02-15 |
Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
Grant 7,172,749 - Levitzki , et al. February 6, 2 | 2007-02-06 |
Targeted double stranded rna mediated cell killing
App 20070010467 - Shir; Alexei ; et al. | 2007-01-11 |
Novel irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and uses thereof for therapy and diagnosis
App 20060025430 - Mishani; Eyal ; et al. | 2006-02-02 |
Compounds for treatment of cell proliferative diseases
App 20050277680 - Priebe, Waldemar ; et al. | 2005-12-15 |
Protein kinase inhibitors
Grant 6,949,565 - Livnah , et al. September 27, 2 | 2005-09-27 |
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
Grant RE38,761 - Levitzki , et al. July 19, 2 | 2005-07-19 |
Catechol bioisosteres
App 20050143430 - Gazit, Aviv ; et al. | 2005-06-30 |
Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
App 20040265228 - Levitzki, Alexander ; et al. | 2004-12-30 |
Method and compositions for inhibiting cell proliferative disorders
App 20040242684 - Chen, Hui ; et al. | 2004-12-02 |
Method for identifying constitutively active mutants of mitogen activated protein kinase (mapk) and uses thereof
App 20040214186 - Engelberg, David ; et al. | 2004-10-28 |
Non-myeloablative tolerogenic treatment with tyrphostins
App 20040197335 - Slavin, Shimon ; et al. | 2004-10-07 |
PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
App 20040132725 - Levitzki, Alexander ; et al. | 2004-07-08 |
Protein kinase inhibitors
App 20040019077 - Livnah, Nurit ; et al. | 2004-01-29 |
PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
Grant 6,673,798 - Levitzki , et al. January 6, 2 | 2004-01-06 |
Selective killing of cells by activation of double-stranded rna dependent protein kniase-pkr
App 20030153083 - Shir, Alexei ; et al. | 2003-08-14 |
Methods and compositions for inhibiting cell proliferative disorders
Grant 6,596,878 - Chen , et al. July 22, 2 | 2003-07-22 |
Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
Grant 6,562,319 - Mishani , et al. May 13, 2 | 2003-05-13 |
Pharmaceutical compositions comprising tyrphostins
App 20030013748 - Novogrodsky, Abraham ; et al. | 2003-01-16 |
Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
App 20020128553 - Mishani, Eyal ; et al. | 2002-09-12 |
Methods and compositions for inhibiting cell proliferative disorders
App 20020068687 - Chen, Hui ; et al. | 2002-06-06 |
PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
App 20020028817 - Levitzki, Alexander ; et al. | 2002-03-07 |
Methods To Modulate The Resistance Of Cells To Apoptosis Mediated By Mutant Epidermal Growth Factor Receptors
App 20010051628 - HUANG, H.-J. SU ; et al. | 2001-12-13 |
Epidermal growth factor receptor binding compounds for positron emission tomography
Grant 6,126,917 - Mishani , et al. October 3, 2 | 2000-10-03 |
Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
Grant 5,981,569 - App , et al. November 9, 1 | 1999-11-09 |
Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis
Grant 5,849,742 - App , et al. December 15, 1 | 1998-12-15 |
Quinazoline compounds and compositions thereof for the treatment of disease
Grant 5,792,771 - App , et al. August 11, 1 | 1998-08-11 |
Methods and compositions for inhibiting cell proliferative disorders
Grant 5,773,476 - Chen , et al. June 30, 1 | 1998-06-30 |
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
Grant 5,763,441 - App , et al. June 9, 1 | 1998-06-09 |
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
Grant 5,712,395 - App , et al. January 27, 1 | 1998-01-27 |
Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
Grant 5,677,329 - Spada , et al. October 14, 1 | 1997-10-14 |
Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase
Grant 5,656,655 - Spada , et al. August 12, 1 | 1997-08-12 |
Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
Grant 5,302,606 - Spada , et al. April 12, 1 | 1994-04-12 |
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
Grant 5,217,999 - Levitzki , et al. June 8, 1 | 1993-06-08 |
Certain indole compounds which inhibit EGF receptor tyrosine kinase
Grant 5,196,446 - Levitzki , et al. March 23, 1 | 1993-03-23 |
| 